On the right hand menu, click PT-1 Request Management. Click Create New PT-1. Follow the instructions and fill out the form. Once the member receives approval for transportation, MassHealth assigns a transportation broker for the member. A broker is a regional transit authority. Only the broker can arrange rides.

2022年11月22日 · 特发性肺纤维化（idiopathic pulmonary fibrosis，IPF）和纤维化超敏性肺炎（fibrotic hypersensitivity pneumonitis，FHP）是ILD的常见原因，但其疾病特征常有重叠，需注意鉴别诊断。 近期CHEST发表的的一篇综述整合各指南意见提出了综合诊断的方法，以下是鉴别诊断要点。 临床特征. IPF和FHP有一些共同的临床特征，但部分不同点可帮助区分（表1）。 常见的共同特征包括呼吸困难、咳嗽、胃食管反流病和吸气性爆裂声。 FHP和IPF一样也存在ILD家 …

过敏性肺炎(Hypersensitivity pneumonitis, HP)是易感和致敏个体吸入多种抗原引起的肺泡炎症或间质纤维化的复杂综合征，可以分为纤维化和非纤维化 HP。纤维化过敏性肺炎（FHP） 是一种致命的间质性肺病，但与特发性肺纤维化（ IPF） 相比，它仍然未被充分研究和了解。

2014年9月27日 · Fibrotic hypersensitivity pneumonitis (FHP) is a specific form of HP defined by chest imaging evidence or pathologic evidence of fibrosis or scarring. Fibrotic HP appears to be irreversible, is often progressive and frequently indistinguishable from other forms of chronic fibrosing interstitial lung diseases (ILD), in particular idiopathic ...

Fibrotic hypersensitivity pneumonitis (fHP) is a chronic, often progressive fibrosing form of interstitial lung disease caused by inhaled antigenic exposures. fHP can lead to impaired respiratory function, reduced disease-related quality of life, and early mortality.

2022年1月28日 · Fibrotic hypersensitivity pneumonitis (FHP) remains one of fatal interstitial pulmonary disease. Comprehensively dissecting the cellular heterogeneity of FHP paves the way...

2022年1月28日 · Fibrotic hypersensitivity pneumonitis (FHP) remains one of fatal interstitial pulmonary disease. Comprehensively dissecting the cellular heterogeneity of FHP paves the way for developing general gene therapeutic solutions for FHP. Here, utilizing an integrated strategy based on scRNA-seq, scTCR-seq, …

2024年7月26日 · Fibrotic hypersensitivity pneumonitis (fHP) is a chronic, often progressive fibrosing form of hypersensitivity pneumonitis and is also often categorized as a form of interstitial lung disease. Manifestations previously categorized as chronic hypersensitivity pneumonitis now fall under this category.

We diagnosed patients with ⩾70% confidence (moderate) of fHP based on HPGL as a new HP guideline-diagnosis fHP (HPGL-fHP). We analyzed transplantation-free survival time, defined as the time from the starting point to death, lung transplantation, lost to …

2022年1月1日 · In fHP, extracellular matrix and antigen presentation/sensitization transcriptomic signatures characterized lung zones with only mild structural and histological changes, whereas signatures involved in honeycombing and B cells dominated the transcriptome in the most severely affected lung zones.